Eli Lilly and Company (NYSE:LLY – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings ...

Eli Lilly and Company (NYSE:LLY – Get Free Report)’s stock price rose 0.1% on Tuesday after Truist Financial raised their price target on the stock from $1,029.00 to $1,038.00. Truist Financial ...

On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher ... partially offset by Zepbound and Humalog. New Products revenue grew by $3.15 billion to $5.64 billion in Q4 2024, led by ...

The company has developed notable medications such as Prozac for depression, Humalog for diabetes, and Mounjaro for type 2 diabetes. Looking closer, Eli Lilly and Company has also outpaced the ...

On Thursday, Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company ... Lower realized prices were primarily driven by Mounjaro, partially offset by Zepbound and Humalog. New Products ...

Lower realized prices were primarily driven by Mounjaro, partially offset by Zepbound and Humalog ... Use Of Eli Lilly’s Ulcerative Colitis Drug For Crohn’s Disease The company reported ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.